All Pathways
Hematology & OncologyDiagnostic

Disseminated Intravascular Coagulation (ISTH 2025)

Disseminated Intravascular Coagulation (ISTH 2025): Suspected DIC → Underlying Disorder Present? → DIC Unlikely.

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Suspected DIC

    Patient with underlying condition and signs of coagulopathy

    1. Decision

      Underlying Disorder Present?

      DIC requires an inciting cause

      • Sepsis/severe infection
      • Trauma/surgery
      • Malignancy (especially APL)
      • Obstetric complications
      • Vascular abnormalities
      • Severe toxic/immunologic reactions
      1. Outcome

        DIC Unlikely

        Consider alternative diagnoses

        • TTP/HUS
        • Liver disease
        • Primary fibrinolysis
        • Heparin effect
      2. Action

        Calculate ISTH DIC Score

        Sum points from 4 parameters

        • Platelet count: >100=0, 50-100=1, <50=2
        • D-dimer: Normal=0, Moderate↑=2, Strong↑=3
        • Prolonged PT: <3s=0, 3-6s=1, >6s=2
        • Fibrinogen: >1.0g/L=0, <1.0g/L=1
        1. Decision

          ISTH DIC Score Result

          Interpret total score

          1. Action

            Score <5: Non-Overt DIC

            May be early or compensated DIC

            • Repeat scoring daily
            • Treat underlying cause aggressively
            • Monitor for progression
            • Consider prophylactic anticoagulation if indicated
            1. Action

              Serial Monitoring

              Repeat DIC score every 12-24 hours

              • CBC with platelets
              • PT/PTT
              • Fibrinogen
              • D-dimer
              • Clinical reassessment
              1. Outcome

                DIC Resolving

                Score decreasing, clinical improvement

              2. Outcome

                DIC Ongoing

                Reassess treatment, consider specialist consult

          2. Warning

            Score ≥5: Overt DIC

            Confirmed DIC - initiate treatment

            1. Action

              Treat Underlying Cause

              Cornerstone of DIC management

              • Antibiotics for sepsis
              • Surgical debridement if needed
              • Delivery for obstetric DIC
              • Chemotherapy for APL (with ATRA)
              • Supportive care
              1. Decision

                Predominant Phenotype?

                Bleeding vs thrombotic manifestations

                1. Action

                  Bleeding Predominant

                  Replacement therapy

                  • Platelets if <20 or <50 with bleeding
                  • FFP if PT/PTT prolonged with bleeding
                  • Cryoprecipitate if fibrinogen <1.5 g/L
                  • Tranexamic acid may be considered
                  • Avoid heparin typically
                2. Action

                  Thrombosis Predominant

                  Consider anticoagulation

                  • UFH or LMWH if no contraindication
                  • Lower prophylactic doses typically
                  • Balance bleeding risk
                  • Protein C concentrate in severe sepsis (purpura fulminans)

Guideline Source

Updated definition and scoring of disseminated intravascular coagulation in 2025: ISTH SSC Subcommittee on DIC

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Scoring system requires laboratory values that may not be immediately available
  • Does not replace clinical judgment for treatment decisions
  • Underlying cause treatment is the cornerstone - not addressed in detail
  • May need adaptation for specific populations (liver disease, pregnancy)

Applicable Regions

USEUGlobal

Global: ISTH scoring system is internationally recognized

Version 1Next review: 2028-01-01

Frequently Asked Questions

What is the Disseminated Intravascular Coagulation (ISTH 2025)?

The Disseminated Intravascular Coagulation (ISTH 2025) is a diagnostic clinical algorithm for Hematology & Oncology. It provides a structured decision tree to guide clinical decision-making, based on Updated definition and scoring of disseminated intravascular coagulation in 2025: ISTH SSC Subcommittee on DIC.

What guideline is the Disseminated Intravascular Coagulation (ISTH 2025) based on?

This algorithm is based on Updated definition and scoring of disseminated intravascular coagulation in 2025: ISTH SSC Subcommittee on DIC (DOI: 10.1016/j.jtha.2025.03.038).

What are the limitations of the Disseminated Intravascular Coagulation (ISTH 2025)?

Known limitations include: Scoring system requires laboratory values that may not be immediately available; Does not replace clinical judgment for treatment decisions; Underlying cause treatment is the cornerstone - not addressed in detail; May need adaptation for specific populations (liver disease, pregnancy). Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Disseminated Intravascular Coagulation (ISTH 2025) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free